View all staff
Professor Robert Read

Professor Robert Read

Chair of Infectious Diseases

Connect with Robert

Email: R.C.Read@soton.ac.uk

Tel: +44 23 8120 6455

ORCID
Research Publications
Research Publications

Research

Research groups

Research projects

Active projects

Safety And Immunogenicity Of Nasal Inoculation With Recombinant Neisseria Lactamica Expressing Factor H Binding Protein And Neisseria Adhesin A
Sponsor: Medical Research Council
Cellulitis optimal antibiotic treatment (COAT) study

Completed projects

Defining upper respiratory colonisation and microbiome evolution in mother-infant pairs following Neisseria lactamica inoculation in late pregnancy
Researchers:
Professor Robert Read
Sponsor: Medical Research Council
Prof R. Read: MRC Experimental Human Challenge with Genetically Modified Commensals to Investigate Respiratory Tract Mucosal Immunity and Colonisation
Sponsor: Medical Research Council
Prof R. Read: A genetically modified nasopharyngeal commensal as a platform for human bacteriotherapy
Sponsor: Medical Research Council
Controlled Human Infection with SARS-CoV-2: Public engagement
Researchers:
Professor Robert Read
Sponsor: Medical Research Council
Understanding the Biology of Neisseria cinerea for the prevention of Meningococcal disease
Researchers:
Professor Robert Read
Sponsor: Meningitis Now
H2020 IMI - PERISCOPE
Researchers:
Professor Robert Read
Sponsor: European Union
Defining the immune response to nasopharyngeal colonisation by the commensal Neissaria lactamica
Researchers:
Professor Robert Read
Sponsor: Wellcome Trust
Pertussis Challenge Study In Adults Vaccinated With BPZE1
Researchers:
Professor Robert Read
Sponsor: ILiAD Biotechnologies, LLC
NIHR Global Health Research Unit on Mucosal Pathogens
Southampton AMR Clinical Research Laboratory
Flexible Raman biosensing platform for low-cost health diagnostics
Sponsor: EPSRC
T Leighton 2015 - EPSRC NAMRA
Sponsor: EPSRC
Impact of Bordetella pertusis colonisation on the upper respiratory tract microbiome
Researchers:
Professor Robert Read
Sponsor: Medical Research Council
A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients
Characterisation Of Peripheral And Tissue Resident Cellular Immune Responses Following Vaccination With The Live, Attenuated, Bordetella Pertussis Vaccine Candidate, BPZE1.
Sponsor: ILiAD Biotechnologies, LLC
H. Morgan, Bacterial Impedance Cytometry for Rapid Antibiotic Susceptibly Testing Ref Number NIHR 200968
S Faust DoH: NISEC - 6 in 1 Hepatitis B virus vaccines
How to edit profile